Global Muscle Stimulator Market to Witness Robust Growth Driven by Rising Prevalence of Chronic Pain and Musculoskeletal Conditions 2030
The global muscle stimulator market is on track for substantial growth in the near future, propelled by the increasing prevalence of muscle injuries, chronic pain, and musculoskeletal conditions among individuals worldwide.
The rising occurrence of chronic pain in the global population, particularly among individuals aged 65 years and above, is a key driver of the muscle stimulator market. According to the Centers for Disease Control and Prevention (CDC), around 30% of adults in this age group suffer from chronic pain. This pain is often managed with prescription drugs, indicating a significant need for effective pain relief solutions. Conditions such as arthritis, migraines, and back pain are also contributing to the demand for muscle stimulators. The World Health Organization (WHO) reported that over 23 million individuals globally suffer from rheumatoid arthritis, and around 1.71 billion individuals are affected by musculoskeletal disorders that result in pain, functional limitations, and mobility issues. These factors are driving the adoption of muscle stimulators for pain relief and rehabilitation.
Furthermore, the increasing popularity of physical fitness activities and outdoor sports is leading to a rise in muscle pain among millennials and adults. Muscle stimulators are being embraced by sports enthusiasts to aid in recovery from injuries, increase strength, relieve pain, facilitate rehabilitation, and assist with warm-up routines. With these benefits in mind, the muscle stimulator market is poised for significant growth.
Growing Demand for TENS Devices
Transcutaneous electrical nerve stimulator (TENS) devices are projected to experience substantial demand, contributing significantly to the growth of the muscle stimulator market. TENS devices are widely used to manage pain signals by blocking them from reaching the brain. These non-invasive electrotherapy devices are effective in treating pain in the lower and upper limbs, making them a sought-after option for pain relief associated with chronic pain, sports injuries, and accidents. Companies are continuously innovating to develop advanced TENS devices. For example, NeuroMetrix announced that its Quell TENS device would undergo clinical trials to assess its efficacy in providing pain relief for patients with neuromyelitis optica spectrum disorders (NMOSD). With such advancements and developments, TENS devices are expected to play a pivotal role in driving the revenue growth of the muscle stimulator market in the coming years.
Regional Outlook: North America and Opportunities for Growth
North America, characterized by developed nations with advanced healthcare infrastructure, has been a significant market for muscle stimulators and is expected to remain so in the future. Factors such as increasing healthcare expenditure, innovations in medical device development, and rising prevalence of musculoskeletal disorders are driving the adoption of muscle stimulators in the region. The impact of the COVID-19 pandemic also highlighted the importance of muscle stimulators, especially respiratory muscle stimulators. Emergency Use Authorization (EUA) was granted to devices like VentFree by the US FDA to reduce muscle atrophy in abdominal walls and decrease the reliance on ventilator support.
Arthritis is another prevalent condition in North America, affecting nearly 20% of the population. Pain relief solutions are in high demand in the region due to the significant impact of pain on the quality of life. The region’s strong economy, increasing GDP per capita, and aging population also contribute to the growth of the muscle stimulator market.
Innovations and Competitive Landscape
The muscle stimulator market is witnessing innovations through new product launches and increased FDA approvals. Companies are introducing novel devices to cater to different pain relief and muscle stimulation needs. For instance, Lutronic launched Accufit, which offers focused muscle stimulation. Cutera Inc. introduced the next generation truSculpt flex with rapid treatment modes. FDA approvals have been granted for devices such as the Cionic Neural Sleeve and wearable electric muscle stimulators like Sky Medical’s Geko, aimed at assisting people with muscle weakness and managing vascular insufficiency.
Key players in the global muscle stimulator market include Beurer GmbH, Zynex Medical, NeuroMetrix Inc., EMS Physio Ltd., DJO Global, Boston Scientific Corporation, Abbott, Cyberonics Inc., RS Medical, Nevro Corp, Omron Healthcare Inc., and Medtronic.
Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 – By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) https://www.fairfieldmarketresearch.com/report/muscle-stimulator-market
Spinal Cord Stimulators Market
Biosensors for Point-of-Care Diagnostics Market
Oral Solid Dosage Manufacturing Market
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
Fairfield Market Research
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
This press release first seen on Brilad